FdaApplication
ANDA 206665
Identifiers
- fda_app_no: ANDA206665
Properties
| Property | Value |
|---|---|
| applicant_name | PH HEALTH LTD |
| application_type | ANDA |
| approval_date | 2019-03-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALISKIREN HEMIFUMARATE | ALISKIREN HEMIFUMARATE | EQ 150MG BASE | TABLET;ORAL |
| ALISKIREN HEMIFUMARATE | ALISKIREN HEMIFUMARATE | EQ 300MG BASE | TABLET;ORAL |
2 products